Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative genome analysis and pathway reconstruction.

Thomas Dandekar1, Rainer Sauerborn

  • 1EMBL, Postfach 102209, D-69012 Heidelberg, Germany. dandekar@embl-heidelberg.de

Pharmacogenomics
|April 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent advances and clinical relevance of microbiome dynamics in health and disease.

Gut microbes·2026
Same author

Diet and microbiome shape small-molecule cytokinin pools in mammals.

Gut microbes·2026
Same author

Integrated Multi-Tissue Transcriptomics Reveals Antagonistic Pleiotropy in Aging and Alzheimer's Disease.

Computational and structural biotechnology journal·2026
Same author

RNA motifs, RNA structure, and motif context analyzed by RNAanalyzer3.

Nucleic acids research·2026
Same author

DNAM-1 mediates NK-cell activation and host-pathogen interaction via direct binding to fungal cell wall proteases.

Communications biology·2026
Same author

Mapping the global health burden of climate-sensitive exposures: a systematic scoping review.

Environmental health : a global access science source·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

Pathway reconstruction uses genome data to map enzyme interactions and analyze metabolite flow. This bioinformatics approach identifies key enzymes and drug targets, accelerating drug development.

Area of Science:

  • Bioinformatics
  • Systems Biology
  • Computational Biology

Background:

  • Pathway reconstruction integrates genomic and biochemical data to understand enzyme interactions within a biological system.
  • Analyzing metabolite flow is crucial for identifying key enzymes and potential pharmacological targets.

Purpose of the Study:

  • To present an overview of bioinformatic tools and algorithms for pathway reconstruction and analysis.
  • To showcase application examples and recent advancements in these techniques.
  • To highlight the potential of these approaches in accelerating drug discovery and development.

Main Methods:

  • Utilizing genome and biochemical data for pathway reconstruction.
  • Employing tools such as elementary mode analysis for metabolite flow analysis.

Related Experiment Videos

  • Reviewing existing bioinformatic tools and algorithms.

    • Main Results:

    • Identification of key enzymes and pharmacological targets within reconstructed pathways.
    • Demonstration of the utility of pathway analysis in various applications.
    • Highlighting the efficiency gains in target selection and drug optimization.

    Conclusions:

    • Bioinformatic approaches to pathway reconstruction and analysis offer significant advantages for drug development.
    • These methods enable faster identification of critical enzymes and therapeutic targets.
    • The presented tools and techniques can expedite the entire drug discovery pipeline.